Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors
- PMID: 9773977
- DOI: 10.1210/mend.12.10.0178
Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors
Abstract
Heterodimerization between thyroid hormone receptors (TRs) and retinoid X receptors (RXRs) is mediated by a weak dimerization interface within the DNA- binding domains (DBDs) and a strong interface within the C-terminal ligand- binding domains of the receptors. Previous studies have shown that the conserved ninth heptad in the TR ligand-binding domain appears to play a critical role in heterodimerization with RXR. However, despite lacking the full ninth heptad, TR variant alpha2 (TRv alpha2) can heterodimerize with RXR on specific direct repeat response elements, but not on palindromic elements or in solution. Two possibilities may account for TRv alpha2-RXR heterodimerization on direct repeats. First, the DBD of TRv alpha2 may play a critical role in heterodimerization with RXR. Second, a specific sequence within the unique C terminus of TRv alpha2 may promote the formation of TRv alpha2-RXR heterodimers. In this study, we used receptor chimeras in which the DBD of RXR was replaced by either the TR DBD or an unrelated DBD from the metalloregulatory transcription factor AMT1 to address the role of the DBD dimerization interface in TRv alpha2-RXR heterodimerization. Gel mobility shift analyses showed that whereas TR alpha1 formed heterodimers with these chimeras, TRv alpha2 failed to do so. Deletion of the unique C terminus of TRv alpha2 had only a marginal effect on heterodimerization with RXR. Mutations within the DBD dimerization interface abolished heterodimerization of full-length TRv alpha2 with RXR but only marginally affected heterodimerization of full-length TR alpha1 with RXR. These data support the hypothesis that the TR-RXR DBD dimerization interface plays a critical role in TRv alpha2-RXR heterodimerization. Additional data show that the amino acid residues that make direct TR-RXR contacts within the DBDs also may play a role in receptor monomer binding to DNA, since mutations within these residues severely impair this interaction.
Similar articles
-
Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors.Mol Endocrinol. 1996 Aug;10(8):958-66. doi: 10.1210/mend.10.8.8843412. Mol Endocrinol. 1996. PMID: 8843412
-
Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.J Cell Biochem. 1999 Dec 1;75(3):462-80. J Cell Biochem. 1999. PMID: 10536369
-
Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein.Mol Endocrinol. 1992 Sep;6(9):1468-78. doi: 10.1210/mend.6.9.1331778. Mol Endocrinol. 1992. PMID: 1331778
-
Ubiquitous receptor: structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones.Ann N Y Acad Sci. 1995 Jun 12;761:38-49. doi: 10.1111/j.1749-6632.1995.tb31367.x. Ann N Y Acad Sci. 1995. PMID: 7625741 Review. No abstract available.
-
How do thyroid hormone receptors bind to structurally diverse response elements?Mol Cell Endocrinol. 1994 Apr;100(1-2):125-31. doi: 10.1016/0303-7207(94)90291-7. Mol Cell Endocrinol. 1994. PMID: 8056146 Review.
Cited by
-
TRα2-An Untuned Second Fiddle or Fine-Tuning Thyroid Hormone Action?Int J Mol Sci. 2022 Jun 23;23(13):6998. doi: 10.3390/ijms23136998. Int J Mol Sci. 2022. PMID: 35806002 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources